BTAI
BioXcel Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.49
-0.06 ▼ -3.87%
🌙 3월 13일 7:50 PM ET (한국 3/14 08:50)
$1.51
+0.02 ▲ +1.34%
| Index | - | P/E | - | EPS (ttm) | -9.7 | Insider Own | 3.89% | Shs Outstand | 0.02B | Perf Week | 0.68% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | 59.57% | Insider Trans | - | Shs Float | 0.02B | Perf Month | -8.02% |
| Enterprise Value | 0.11B | PEG | - | EPS next Q | -0.64 | Inst Own | 17.07% | Short Float | 8.93% | Perf Quarter | -31.96% |
| Income | -0.07B | P/S | 48.37 | EPS this Y | 72.33% | Inst Trans | 1.81% | Short Ratio | 1.4 | Perf Half Y | -56.05% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 59.26% | ROA | -145.62% | Short Interest | 1.88M | Perf YTD | -6.88% |
| Book/sh | -4.45 | P/C | 0.97 | EPS past 3/5Y | 28.7% 6.2% | ROE | - | 52W High | -81.56% ($8.08) | Perf Year | -33.63% |
| Cash/sh | 1.53 | P/FCF | - | Sales past 3/5Y | - | ROIC | -2016.29% | 52W Low | 27.35% ($1.17) | Perf 3Y | -99.57% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 71.83% | Gross Margin | -68.48% | Volatility(W/M) | 13.97% 8.69% | Perf 5Y | -99.8% |
| Dividend TTM | - | EV/Sales | 144.33 | Sales Y/Y TTM | -66.96% | Oper. Margin | -6599.34% | ATR (14) | 0.15 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.16 | EPS Q/Q | 57.74% | Profit Margin | -9070.61% | RSI (14) | 42.91 | Recom | 1.75 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.17 | Sales Q/Q | -54.21% | SMA20 | -7.31% ($1.61) | Beta | 0.23 | Target Price | $14.25 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -11.87% ($1.69) | Rel Volume | 0.52 | Prev Close | $1.55 |
| Employees | 37 | LT Debt/Eq | - | EPS/Sales Surpr. | -62.69% -54.78% | SMA200 | -34.46% ($2.27) | Avg Volume(3M) | 1.34M | Price | $1.49 |
| IPO | 2018/3/8 | Option/Short | No/Yes | Trades | 1602 | Volume | 700,318 | Change | -3.87% |
뉴스 로딩 중...